The SCN11A gene helps pain sensing nerves send electrical signals, especially in the body’s outer nerves. If it does not work normally, these signals can become too strong or too weak, which may lead to burning pain, repeated pain episodes, tingling, or reduced ability to feel pain. Some people with SCN11A variants develop small fiber neuropathy, a condition that affects tiny nerves in the skin and limbs. Effects vary widely, even within the same family.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Other genes mainly help manage when certain processes happen, where they take place, and how active they are. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medicines. To explore this topic in more detail, you can learn more in the LearnHub.
Overview
SCN11AGene function
What if the gene works
The SCN11A gene gives nerve cells instructions for a sodium channel called NaV1.9. This channel helps pain sensing nerves, and some gut nerves, send signals and respond to touch, temperature, and pain.
Risk
What if the gene does not work
Variants in the SCN11A gene can alter pain signaling, causing intense pain episodes in some people and reduced pain sensation in others. Effects can range from milder to more severe depending on the variant, sometimes with tingling or bowel symptoms.
Treatment
What does that mean for your treatment
For pathogenic or loss-of-function variants in the SCN11A gene, no gene-specific treatment or management approach is currently established in clinical guidelines. The SCN11A gene is an active pain research target, and drugs that aim to reduce Nav1.9 channel activity are being studied in early-stage research.
Conditions associated with SCN11A
Gene function
What if the gene works
A key part of SCN11A gene function is helping pain-sensing nerves send electrical messages. It is most active in peripheral sensory nerves, which carry information from the body toward the spinal cord and brain. When it works normally, it helps fine-tune how easily these nerves respond.
The SCN11A gene provides instructions for a sodium channel in sensory nerve cells. This channel opens to let sodium move into the cell, which helps create an electrical signal.
Its channel is active close to a nerve cell’s resting state, so it helps set how easily the cell responds. This gives pain-sensing nerves a steady baseline for sending messages when needed.
The channel made from the SCN11A gene is found mainly in peripheral sensory nerves, including nerves that detect painful or irritating stimuli. This supports normal communication from the body to the spinal cord and brain.
What is a variant?
A genetic variant is a slight change in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many SCN11A gene variants change the NaV1.9 sodium channel so it opens too easily, stays active longer, or lets in a small extra sodium leak. In plain terms, this is how SCN11A gene variants affect pain signaling cells: many make these nerve cells more excitable, while stronger activating variants can keep them so electrically overcharged that they stop firing normally. Milder variants may cause a smaller change in channel activity, while more disruptive variants can have earlier or broader effects.
How variants are linked to conditions
Pathogenic variants in the SCN11A gene are most clearly linked to inherited pain conditions. They can cause familial episodic pain syndrome type 3, which brings repeated attacks of pain, often starting in childhood. Some SCN11A gene variants have also been associated with painful small fiber neuropathy and, in a smaller number of families, reduced pain sensation.
A variant is not necessarily a diagnosis
Gene variants are a usual part of human biology and are common across the general population. Most do not directly affect health and simply reflect normal human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a confirmed diagnosis, especially when several genes and environmental factors also play a role. In some cases, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risks related to the SCN11A gene. In families with an SCN11A change, symptoms can vary from person to person, so personal risk is best discussed with a doctor or genetic counselor.
Inheritance of SCN11A variants
SCN11A-related conditions usually follow an autosomal dominant inheritance pattern. This means a parent with a disease-causing variant in the SCN11A gene can pass it to a child with a 50% chance in each pregnancy, and it can be inherited by sons or daughters. Some cases happen because of a new, de novo variant, so the change is not inherited from either parent. In practice, the SCN11A inheritance pattern means one altered copy of the gene can be enough to cause symptoms.
What does my SCN11A result mean for my family?
For SCN11A, the family impact is usually in line with a dominant pattern, which means close relatives such as a parent, brother, sister, or child may also carry the same gene change. Some may have pain-related symptoms, numbness, or other nerve symptoms, while others can be affected more mildly. Because the effects can vary from one family member to another, the meaning for relatives depends on the exact SCN11A result and the condition linked to it.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the SCN11A gene, doctors use genetic testing for SCN11A variants, usually with a blood sample or saliva sample. A lab reads the DNA code in this gene and compares it with the usual sequence, then reports whether a variant was found and how it is classified.
When should I consider getting a genetic test?
Consider SCN11A testing if there is unexplained severe burning pain that comes and goes, especially starting in infancy or childhood, or an unusually low ability to feel pain. Testing may also help when several relatives have similar symptoms, because some SCN11A changes can run in families.
A genetic result is only one part of your health story
A genetic finding can offer useful insight, but how much it explains varies by the condition and the type of variant involved. Over time, factors such as lifestyle, environment, age, and medical history also influence how the body functions. In some conditions, especially those shaped by many genes, genetic information adds context rather than certainty and is best understood as part of the broader picture of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down a drug more slowly or more quickly, while others may be more or less sensitive to its effects. This helps explain why the same treatment can work well for one person, have less effect in another, or cause more side effects in someone else. These differences are common and are one part of why medication response varies from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medications. It looks at the relationship between genes and drugs to help explain why treatments can work differently from one person to another. For many medicines, genes influence both how the body processes a drug and how strong its effects may be. This information can support treatment decisions that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the SCN11A gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in choosing or adjusting medicines. If you have concerns about symptoms, side effects, or how a medicine is working, discuss them with your doctor.
History
SCN11A entered the medical literature as researchers mapped genes involved in nerve signaling and inherited pain conditions. In recent decades, awareness of this gene’s role has grown. A major turning point came in the 2010s, when variants in the SCN11A gene were linked to unusual pain patterns in families, including people with very high pain sensitivity and others with reduced ability to feel pain. These findings helped expand the study of inherited pain beyond better known sodium channel genes. From these first observations, research expanded steadily. SCN11A is now recognized as part of the modern history of pain genetics, especially in efforts to understand why pain experiences can differ so much from one person to another.